Evidence map›Paper›PMID 29908907›Full record

ArticleJournal of autoimmunity2018

Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells.

Johannes Nowatzky, Olivier Manches, Shaukat Ali Khan, Emmanuelle Godefroy, Nina Bhardwaj

Abstract read
In one paragraph

Article in Journal of autoimmunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Autoimmunity in 2018.Clinical reviews in allergy & immunology · 2019
    Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Johannes NowatzkyNew York University School of Medicine, New York, NY, USA.
Olivier ManchesNew York University School of Medicine, New York, NY, USA.
Shaukat Ali KhanNew York University School of Medicine, New York, NY, USA.
Emmanuelle GodefroyNew York University School of Medicine, New York, NY, USA.
Nina BhardwajNew York University School of Medicine, New York, NY, USA. Electronic address: nina.bhardwaj@mssm.edu.
New York University · US

Funding

Modulating Immunity through Dendritic Cell Phagocytic ReceptorsR01AI071078 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BHARDWAJ, NINA · 2008 to 2011
$1.7M
Harnessing monoclonal Treg for the treatment of autoimmune uveitisK08EY025324 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NOWATZKY, JOHANNES · 2015 to 2019
$907k
NEI NIH HHS K08 EY025324NIAID NIH HHS R01 AI071078
6 · The paper itself

Abstract

objectiveApoptotic cell receptors contribute to the induction of tolerance by modulating dendritic cell function following the uptake of apoptotic cells or microparticles. Dendritic cells that have bound or ingested apoptotic cells produce only low amounts of pro-inflammatory cytokines and fail to prime effector T cell responses. Specifically, ligation of the apoptotic cell receptor CR3 (CD11 b/CD18) on human monocyte-derived dendritic cells (moDC) down-modates proinflammatory cytokine secretion, but the consequences for human Th17 cell homeostasis and effector responses remain unknown. Here, we aimed to establish whether CD11b-ligated moDC modulate Th17 cell effector reponses to assess their potential for future use in moDC-based suppressive immunotherapy.

methodsWe generated a bead-based surrogate system to target CD11b on monocyte-derived human dendritic cells and examined the effects of CD11b ligation on Th17-skewing cytokine secretion, priming, expansion and functional plasticity in DC/T cell co-culture systems at the poly- and monoclonal level.

resultsWe show that Th17 cell expansion within the human memory CD4

conclusionOverall, our findings underline the potential of targeted CD11b ligation on human dendritic cells for the engineering of suppressive immunotherapy for Th17-related autoimmune disorders.

Indexed as

CD18 AntigensCell DifferentiationCell PlasticityCell ProliferationCells, CulturedCoculture TechniquesCytokinesDendritic CellsGenetic Predisposition to DiseaseHumansImmune ToleranceImmunologic MemoryImmunotherapy, AdoptiveLupus Erythematosus, SystemicLymphocyte ActivationMacrophage-1 AntigenCD18 AntigensCytokinesMacrophage-1 AntigenAutoimmunityCD11bHuman monocyte-derived dendritic cellsHuman Th17 cellsImmunotherapy

Identifiers

PMID29908907
PMCPMC6498856
OpenAlexW2808402579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.